Param P. Sharma
Marshfield Clinic
11 Papers
106 Citations
Param P. Sharma is an academic researcher from Marshfield Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 11 publications.
Chat about Author
Papers
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use.
TL;DR: After verapamil therapy and cessation of marijuana, the patient's coronary flow normalized and ventricular tachycardia was no longer inducible in the electrophysiologic laboratory.
115
Swallow Syncope: A Case Report and Review of the Literature
TL;DR: A woman, aged 60 years, presented with an episode of a syncopal attack associated with swallowing a sandwich, which resolved after permanent pacemaker placement.
46
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results from the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators
Pamela N. Peterson,Robert T. Greenlee,Alan S. Go,David J. Magid,Andrea E. Cassidy-Bushrow,Romel Garcia-Montilla,Karen A. Glenn,Jerry H. Gurwitz,Stephen C. Hammill,John J. Hayes,Alan H. Kadish,Kristi Reynolds,Param P. Sharma,David H. Smith,Paul D. Varosy,Paul D. Varosy,Humberto Vidaillet,Chan X. Zeng,Sharon-Lise T. Normand,Frederick A. Masoudi,Frederick A. Masoudi +20 more
TL;DR: Among patients who received an ICD for primary prevention without indications for pacing, dual‐chamber devices were not associated with lower risk of inappropriate shock or differences in hospitalization or death compared with single‐ chamber devices.
Familial atrioventricular nodal reentry tachycardia.
TL;DR: Electrophysiological evidence of dual atrioventricular nodal pathways was established in all 13 patients studied, AVNRT was induced in 12 (92%), and radiofrequency ablation of the slow pathway was curative in all cases.
27
Longitudinal Study of Implantable Cardioverter-Defibrillators Methods and Clinical Characteristics of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention in Contemporary Practice
Frederick A. Masoudi,Alan S. Go,David J. Magid,Andrea E. Cassidy-Bushrow,Jonathan M. Doris,Frances Fiocchi,Romel Garcia-Montilla,Karen A. Glenn,Robert J. Goldberg,Nigel Gupta,Jerry H. Gurwitz,Stephen C. Hammill,John J. Hayes,Nathaniel Jackson,Alan H. Kadish,Michael R. Lauer,Aaron W. Miller,Deborah Multerer,Pamela N. Peterson,Liza M. Reifler,Kristi Reynolds,Jane S. Saczynski,Claudio Schuger,Param P. Sharma,David H. Smith,Mary Suits,Sue Hee Sung,Paul D. Varosy,Humberto Vidaillet,Robert T. Greenlee +29 more
TL;DR: Patients undergoing primary prevention ICD implantation in this study differ from those enrolled in the randomized, controlled trials that established the efficacy of ICDs, which will provide patients, clinicians, and policy makers with contemporary data to inform decision-making.
26